Position in BIOA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,501,343
-$1,360,788 QoQ
Shares Held
224,453
-42.8% QoQ
Ownership
0.489%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#36
of 151 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $533,943,071 across 32 Drug Manufacturers - Specialty & Generic names. BIOA ranks #14 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
318,320 | $172,475,325 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
441,371 | $74,388,668 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
679,083 | $43,427,357 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
2,260,243 | $32,750,921 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
733,974 | $30,114,953 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,650,255 | $28,565,914 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
5,482,986 | $27,031,120 | |
| 8 | ZTS |
Zoetis Inc.
|
364,442 | $26,188,802 |
All Filings in BIOA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,501,343 | 224,453 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,862,131 | 392,346 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,677,371 | 277,957 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $62,774 | 10,676 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $12,133 | 2,938 | Shares | Defined | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||